BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 21090965)

  • 61. Hepatic plasmacytosis as a manifestation of relapse in multiple myeloma treated with thalidomide.
    del Giglio A; Weinschenker P; Manhani AR; Carbonell AL; Mitteldorf CA
    South Med J; 2005 Feb; 98(2):238-40. PubMed ID: 15759959
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [The plasma cell myeloma--molecular pathogenesis and target therapies].
    Hess U
    Ther Umsch; 2006 Apr; 63(4):233-6. PubMed ID: 16689452
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Plasma cell leukemia].
    Ravinet A; Bay JO; Tournilhac O
    Bull Cancer; 2014 Nov; 101(11):1048-58. PubMed ID: 25418598
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Multiple myeloma: the present and the future.
    Joshua DE
    Med J Aust; 2005 Oct; 183(7):344. PubMed ID: 16201949
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Prognostic significance of morphology in multiple myeloma].
    Al-Sahmani M; Trnavská I; Antošová M; Antošová L; Kissová J; Kaisarová B; Adam Z; Buliková A; Penka M; Hájek R
    Klin Onkol; 2012; 25(2):103-9. PubMed ID: 22533884
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Plasma cell leukaemia and other aggressive plasma cell malignancies.
    Sher T; Miller KC; Deeb G; Lee K; Chanan-Khan A
    Br J Haematol; 2010 Aug; 150(4):418-27. PubMed ID: 20701603
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Multiple myeloma: Updates for pharmacists in the treatment of relapsed and refractory disease.
    Ashjian E; Redic K
    J Oncol Pharm Pract; 2016 Apr; 22(2):289-302. PubMed ID: 25694345
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Multiple myeloma: from diagnosis to treatment.
    Eslick R; Talaulikar D
    Aust Fam Physician; 2013 Oct; 42(10):684-8. PubMed ID: 24130968
    [TBL] [Abstract][Full Text] [Related]  

  • 69. An overview of the progress in the treatment of multiple myeloma.
    Kyle RA; Rajkumar SV
    Expert Rev Hematol; 2014 Feb; 7(1):5-7. PubMed ID: 24433105
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Multiple myeloma: Updated approach to management in 2018.
    Tomlinson R
    Aust J Gen Pract; 2018 Aug; 47(8):526-529. PubMed ID: 30114882
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Novel targets for myeloma bone disease.
    Roodman GD
    Expert Opin Ther Targets; 2008 Nov; 12(11):1377-87. PubMed ID: 18851694
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Drug-mediated and cellular immunotherapy in multiple myeloma.
    Ritchie DS; Quach H; Fielding K; Neeson P
    Immunotherapy; 2010 Mar; 2(2):243-55. PubMed ID: 20635931
    [TBL] [Abstract][Full Text] [Related]  

  • 73. What is the evidence for the use of bisphosphonate therapy in newly diagnosed multiple myeloma patients lacking bone disease?
    Locke FL; Morgan GJ
    Hematology Am Soc Hematol Educ Program; 2012; 2012():350-3. PubMed ID: 23233603
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Moving disease biology from the laboratory to the clinic.
    Anderson KC
    Semin Oncol; 2002 Dec; 29(6 Suppl 17):17-20. PubMed ID: 12520480
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Novel approaches for the treatment of NHL: Proteasome inhibition and immune modulation.
    O'Connor OA; Czuczman MS
    Leuk Lymphoma; 2008; 49 Suppl 1():59-66. PubMed ID: 18821434
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Targeting the bone marrow microenvironment in multiple myeloma.
    Kawano Y; Moschetta M; Manier S; Glavey S; Görgün GT; Roccaro AM; Anderson KC; Ghobrial IM
    Immunol Rev; 2015 Jan; 263(1):160-72. PubMed ID: 25510276
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Update in multiple myeloma: international criteria for treatment response and renal complications].
    Decaux O; Karras A
    Rev Med Interne; 2009 Dec; 30(12):1080-3. PubMed ID: 19833418
    [No Abstract]   [Full Text] [Related]  

  • 78. Targeted therapy of multiple myeloma.
    Dolloff NG; Talamo G
    Adv Exp Med Biol; 2013; 779():197-221. PubMed ID: 23288641
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Novel targeted therapy in multiple myeloma].
    Izumi T
    Nihon Rinsho; 2014 Jun; 72(6):1089-93. PubMed ID: 25016809
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Multiple myeloma presenting with hepatosplenomegaly.
    Mallavarapu KM; Rajappa S; Linga VG; Gundeti S; Digumarthi R; Uppin SG
    J Assoc Physicians India; 2011 Jul; 59():456-8. PubMed ID: 22315756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.